
A multi-cancer early detection blood test that screens for a signal shared by many cancers, including several with no routine screening program.
One-time $999
Next: pick your state, pick a time, then talk to a clinician, about two minutes.
Your first call with our care team is always free. If you decide to move forward, a separate medical consultation is required before any prescription can be issued.

Screens for signals associated with over 50 cancer types
May identify cancer signals before symptoms appear
Helps identify where a detected cancer signal originated
Screens for multiple cancer signals through one blood draw
Cancer cells shed DNA into the bloodstream. Galleri looks for methylation patterns on that circulating DNA that are characteristic of cancer, and, if it finds a signal, predicts where in the body it originated.
It is designed to sit alongside standard screening, not replace it. Mammograms, colonoscopy and the rest still apply.
A positive result is a reason for diagnostic follow-up, not a diagnosis. A negative result does not mean cancer is absent.

Analyzes DNA patterns associated with cancer signals
Helps distinguish cancer signals from noncancerous patterns
Screens for cancers lacking routine screening options
Helps physicians determine appropriate follow-up testing
PROTOCOL
A typical schedule. Yours is set by your clinician, and adjusted as you go.
PHASE
WEEKS
TYPICAL
PURPOSE
Order
Day 0
Provider order required
A provider reviews suitability first .
Draw
Days 1-5
Single blood draw
At a national lab .
Results .
~2-3 weeks
Provider review
Positive results are discussed , never emailed cold.
Requires a doctor's order and a conversation about what a result means.
One tube, one visit.
Reviewed with a provider, with a follow-up plan if needed.

Galleri detects a shared cancer signal across many cancer types and predicts the likely origin. Detection rates vary substantially by cancer type and stage, and are higher in later stages.
It is intended to complement, not replace, guideline-recommended screening.
A negative result does not rule out cancer. Continue with all standard screening you are due.
Results vary. Clinical trial results apply only to the FDA-approved branded medication specifically identified and do not apply to compounded medications. All medications must be prescribed by a licensed provider based on medical necessity.
No. It means no cancer signal was detected in that sample. Many cancers, particularly early ones, shed too little DNA to be found this way. Keep up with your usual screening.
Your provider arranges diagnostic follow-up, usually imaging, guided by the predicted origin. A positive signal is not a diagnosis.
Annually is the usual pattern, but that is a conversation with your provider rather than a rule.

Physician-Prescribed, Personalized Medicine for Weight, Hormones, Peptide Therapy, Metabolic Health & Longevity Across All 50 States
Contact Us
3717 E Thousand Oaks Blvd, Ste 170
Westlake Village, CA 91362
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. Compounded medications are not FDA-approved. Results may vary